Biomerica Inc. has received authorization from the Egyptian Drug Authority (EDA) for its complete portfolio of rapid screening tests. The approval allows Biomerica to market and distribute its at-home tests for colorectal disease, breast self-exam, prostate disease, kidney disease, and H. pylori infection throughout Egypt. These rapid, easy-to-use, and cost-effective tests are designed for early detection of cancers and chronic diseases, supporting both individual and mass population screenings. The authorization is expected to strengthen preventive healthcare efforts and expand Biomerica's presence in the Middle East and North Africa region. No grants or funding involving other organizations were mentioned.